| Basics |
Lifevantage Corporation
Lifevantage Corp is engaged in the identification, research, development and distribution of nutraceutical dietary supplements and skin care products including Protandim, LifeVantage TrueScience and Canine Health.
|
| IPO Date: |
May 1, 1994 |
| Sector: |
Consumer Staples |
| Industry: |
Personal Products |
| Market Cap: |
$168.3M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.19 | 2.64%
|
| Avg Daily Range (30 D): |
$0.33 | 2.65%
|
| Avg Daily Range (90 D): |
$0.49 | 3.03%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.15M |
| Avg Daily Volume (30 D): |
.17M |
| Avg Daily Volume (90 D): |
.2M |
| Trade Size |
| Avg Trade Size (Sh.): |
194 |
| Avg Trade Size (Sh.) (30 D): |
67 |
| Avg Trade Size (Sh.) (90 D): |
69 |
| Institutional Trades |
| Total Inst.Trades: |
75 |
| Avg Inst. Trade: |
$1.74M |
| Avg Inst. Trade (30 D): |
$.51M |
| Avg Inst. Trade (90 D): |
$.82M |
| Avg Inst. Trade Volume: |
.15M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.27M |
| Avg Closing Trade (30 D): |
$.52M |
| Avg Closing Trade (90 D): |
$.71M |
| Avg Closing Volume: |
301.29K |
|
|
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.28
|
$.21
|
|
Diluted EPS
|
|
$.26
|
$.19
|
|
Revenue
|
$
|
$ 58.44M
|
$ 67.76M
|
|
Gross Profit
|
$
|
$ 47.33M
|
$ 54.57M
|
|
Net Income / Loss
|
$
|
$ 3.47M
|
$ 2.55M
|
|
Operating Income / Loss
|
$
|
$ 4.05M
|
$ 3.43M
|
|
Cost of Revenue
|
$
|
$ 11.11M
|
$ 13.2M
|
|
Net Cash Flow
|
$
|
$ .87M
|
$ 7M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 19, 2015:
1:7
|
|
Oct 05, 2004:
1:68
|
|
